AVTR Stock Overview
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Avantor, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$23.82 |
| 52 Week High | US$38.83 |
| 52 Week Low | US$17.91 |
| Beta | 1.36 |
| 1 Month Change | 17.75% |
| 3 Month Change | 23.93% |
| 1 Year Change | -34.38% |
| 3 Year Change | 28.97% |
| 5 Year Change | n/a |
| Change since IPO | 64.28% |
Recent News & Updates
With EPS Growth And More, Avantor (NYSE:AVTR) Makes An Interesting Case
Jan 09
Here's Why Avantor (NYSE:AVTR) Can Manage Its Debt Responsibly
Dec 27Is It Time To Consider Buying Avantor, Inc. (NYSE:AVTR)?
Dec 14Recent updates
With EPS Growth And More, Avantor (NYSE:AVTR) Makes An Interesting Case
Jan 09Here's Why Avantor (NYSE:AVTR) Can Manage Its Debt Responsibly
Dec 27Is It Time To Consider Buying Avantor, Inc. (NYSE:AVTR)?
Dec 14Estimating The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)
Oct 27Do Avantor's (NYSE:AVTR) Earnings Warrant Your Attention?
Oct 03We Think Avantor (NYSE:AVTR) Can Stay On Top Of Its Debt
Sep 21Is Avantor, Inc. (NYSE:AVTR) Potentially Undervalued?
Sep 09Estimating The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)
Jul 18Avantor, Inc.'s (NYSE:AVTR) P/E Is On The Mark
Jul 05Here's Why Avantor (NYSE:AVTR) Can Manage Its Debt Responsibly
Jun 20I Ran A Stock Scan For Earnings Growth And Avantor (NYSE:AVTR) Passed With Ease
May 15A Look At The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)
Apr 08Avantor (NYSE:AVTR) Has A Pretty Healthy Balance Sheet
Feb 04Here's Why We Think Avantor (NYSE:AVTR) Is Well Worth Watching
Jan 20Does This Valuation Of Avantor, Inc. (NYSE:AVTR) Imply Investors Are Overpaying?
Jan 05Is Now An Opportune Moment To Examine Avantor, Inc. (NYSE:AVTR)?
Nov 14These 4 Measures Indicate That Avantor (NYSE:AVTR) Is Using Debt Reasonably Well
Oct 30If You Like EPS Growth Then Check Out Avantor (NYSE:AVTR) Before It's Too Late
Aug 21Here's Why Avantor (NYSE:AVTR) Can Manage Its Debt Responsibly
Jul 09What Is Avantor, Inc.'s (NYSE:AVTR) Share Price Doing?
Jun 11Avantor, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Apr 30Avantor, Inc. (NYSE:AVTR) Shares Could Be 27% Above Their Intrinsic Value Estimate
Apr 12Avantor (NYSE:AVTR) Has A Pretty Healthy Balance Sheet
Mar 16What Type Of Shareholders Own The Most Number of Avantor, Inc. (NYSE:AVTR) Shares?
Feb 18
Avantor (NYSE:AVTR) Shareholders Booked A 60% Gain In The Last Year
Feb 01Is Avantor, Inc.'s (NYSE:AVTR) ROE Of 5.3% Concerning?
Jan 11Is Avantor, Inc. (NYSE:AVTR) Expensive For A Reason? A Look At Its Intrinsic Value
Dec 16Shareholder Returns
| AVTR | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 3.5% | -1.1% | 2.3% |
| 1Y | -34.4% | -9.3% | -9.7% |
Return vs Industry: AVTR underperformed the US Life Sciences industry which returned -6.9% over the past year.
Return vs Market: AVTR underperformed the US Market which returned -8.5% over the past year.
Price Volatility
| AVTR volatility | |
|---|---|
| AVTR Average Weekly Movement | 5.8% |
| Life Sciences Industry Average Movement | 11.8% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: AVTR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: AVTR's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 13,500 | Michael Stubblefield | https://www.avantorsciences.com |
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies.
Avantor, Inc. Fundamentals Summary
| AVTR fundamental statistics | |
|---|---|
| Market Cap | US$16.06b |
| Earnings (TTM) | US$598.40m |
| Revenue (TTM) | US$7.63b |
26.8x
P/E Ratio2.1x
P/S RatioIs AVTR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AVTR income statement (TTM) | |
|---|---|
| Revenue | US$7.63b |
| Cost of Revenue | US$4.99b |
| Gross Profit | US$2.64b |
| Other Expenses | US$2.04b |
| Earnings | US$598.40m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Feb 03, 2023
| Earnings per share (EPS) | 0.89 |
| Gross Margin | 34.57% |
| Net Profit Margin | 7.85% |
| Debt/Equity Ratio | 133.3% |
How did AVTR perform over the long term?
See historical performance and comparison